![](/img/cover-not-exists.png)
Liver injury with dipeptidyl peptidase-4 (DPP-4) inhibitors (GLIPTINS): signals emerging from the us-fda adverse event reporting system
Raschi, E., Poluzzi, E., Koci, A., Antonazzo, I.C., De Ponti, F.Volume:
37
Language:
english
Journal:
Clinical Therapeutics
DOI:
10.1016/j.clinthera.2015.05.306
Date:
August, 2015
File:
PDF, 47 KB
english, 2015